ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near London, England, GBR:

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity (SINT1A)

months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...

Enrolling
Diabetes Mellitus, Type 1
Dietary Supplement: B. infantis
Dietary Supplement: Placebo
Helmholtz Zentrum München

Cambridge, United Kingdom and 7 other locations

A trial of patients with type 2 diabetes mellitus to evaluate the comparative effectiveness between dapagliflozin and Standard of Care (SOC)...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Dapagliflozin
Drug: Standard of Care

Phase 4

University of Liverpool

London, United Kingdom and 128 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

London, United Kingdom and 64 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

London, United Kingdom and 45 other locations

+ 12-week 800kcal/day low-energy diet, delivered remotely) is more likely to lead to weight loss and remission in adults with type 2 diabetes...

Invitation-only
Diabetes Mellitus, Type 2
Other: Standard of care
Combination Product: Digital therapeutic and intensive lifestyle programme
Habitual Health

London, United Kingdom

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

London, United Kingdom and 89 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Stevenage, Hertfordshire, United Kingdom and 44 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Cambridge, United Kingdom and 37 other locations

will be intravenously infused into participants with type 2 diabetes (T2DM). Overall, the aim of the study is to further the investigator's ...

Enrolling
Type 2 Diabetes
Obesity
Drug: Exenatide (50ng/min for 30 minutes loading followed by 25ng/min maintenance) and glucagon 12.5ng/kg/min
Drug: 0.9% Sodium-chloride

Phase 4

NHS Foundation Trust
NHS Foundation Trust

Cambridge, Cambridgeshire, United Kingdom

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

London, United Kingdom and 78 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems